COVID-19 : Still a place for the convalescent plasma? Focus on the immunocompromised patients
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
La Revue de medecine interne - 44(2023), 9 vom: 07. Sept., Seite 467-471 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Covid-19 : encore une place pour le plasma de convalescent ? Focus sur les patients immunodéprimés |
|---|
| Beteiligte Personen: |
Richier, Q [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 02.10.2023 Date Revised 06.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.revmed.2023.08.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361870116 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361870116 | ||
| 003 | DE-627 | ||
| 005 | 20231226090048.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.revmed.2023.08.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM361870116 | ||
| 035 | |a (NLM)37689526 | ||
| 035 | |a (PII)S0248-8663(23)00712-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Richier, Q |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 |b Still a place for the convalescent plasma? Focus on the immunocompromised patients |
| 246 | 3 | 3 | |a Covid-19 : encore une place pour le plasma de convalescent ? Focus sur les patients immunodéprimés |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.10.2023 | ||
| 500 | |a Date Revised 06.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Convalescent plasma | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a Immunocompromised | |
| 650 | 4 | |a Immunodéprimés | |
| 650 | 4 | |a Plasma de convalescent | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Sars-CoV-2 | |
| 650 | 7 | |a Immunoglobulin G |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Hueso, T |e verfasserin |4 aut | |
| 700 | 1 | |a Tiberghien, P |e verfasserin |4 aut | |
| 700 | 1 | |a Lacombe, K |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t La Revue de medecine interne |d 1983 |g 44(2023), 9 vom: 07. Sept., Seite 467-471 |w (DE-627)NLM012660108 |x 1768-3122 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2023 |g number:9 |g day:07 |g month:09 |g pages:467-471 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.revmed.2023.08.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2023 |e 9 |b 07 |c 09 |h 467-471 | ||